Curcumin augments lung maturation, preventing neonatal lung injury by inhibiting TGF-β signaling

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 301, Issue 5, 2011, Pages

  Sakurai, Reiko ^a   Li, Yishi ^a   Torday, John S ^a   Rehan, Virender K ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Bronchopulmonary dysplasia; Hyperoxia; Transforming growth factor

Indexed keywords

ADIPOPHILIN; ALPHA SMOOTH MUSCLE ACTIN; CURCUMIN; FIBRONECTIN; OXYGEN; PARATHYROID HORMONE RELATED PROTEIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SMAD3 PROTEIN; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRIOLEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; EPITHELIUM CELL; FETUS; FETUS LUNG MATURATION; HYPEROXIA; LUNG ALVEOLUS CELL; LUNG DYSPLASIA; LUNG FIBROBLAST; LUNG INJURY; MESENCHYME CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; BRONCHOPULMONARY DYSPLASIA; CELL DIFFERENTIATION; CURCUMIN; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; HYPEROXIA; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LUNG; PARATHYROID HORMONE-RELATED PROTEIN; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PPAR GAMMA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PARATHYROID HORMONE, TYPE 1; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 80055108237     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00076.2011     Document Type: Article

References (39)

1. Bisht K, Wagner KH, Bulmer AC. Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds. Toxicology 278: 88-100, 2010.
2. Boros LG, Torday JS, Paul Lee WN, Rehan VK. Oxygen-induced metabolic changes and transdifferentiation in immature fetal rat lung lipofibroblasts. Mol Genet Metab 77: 230-236, 2002.
3. Cerny L, Torday JS, Rehan VK. Prevention and treatment of bronchopulmonary dysplasia: contemporary status and future outlook. Lung 186: 75-89, 2008.
4. Chen B, Zhang DP, Gao W. [Effect of curcumin on the expression of collagen type I protein and transforming growth factor-β1 mRNA in pulmonary fibrosis rats]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 26: 257-261, 2008.
5. Dasgupta C, Sakurai R, Wang Y, Guo P, Ambalavanan N, Torday JS, Rehan VK. Hyperoxia-induced neonatal rat lung injury involves activation of TGF-β and Wnt signaling and is protected by rosiglitazone. Am J Physiol Lung Cell Mol Physiol 296: L1031-L1041, 2009.
6. Epstein J, Sanderson IR, Macdonald TT. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr 103: 1545-1557, 2010.
7. Hayes D Jr, Feola DJ, Murphy BS, Shook LA, Ballard HO. Pathogenesis of bronchopulmonary dysplasia. Respiration 79: 425-436, 2010.
8. Jacob A, Wu R, Zhou M, Wang P. Mechanism of the anti-inflammatory effect of curcumin: PPAR-γ activation. PPAR Res 2007: 89369, 2007.
9. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 46: 641-643, 1999.
10. Kalpana C, Menon VP. Inhibition of nicotine-induced toxicity by curcumin and curcumin analog: a comparative study. J Med Food 7: 467-471, 2004.
11. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91: 7355-7359, 1994.
12. Kwong KY, Niang S, Literat A, Zhu NL, Ramanathan R, Jones CA, Minoo P. Expression of transforming growth factor β (TGF-β1) by human preterm lung inflammatory cells. Life Sci 79: 2349-2356, 2006.
13. Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6: 10, 2006.
14. Lecart C, Cayabyab R, Buckley S, Morrison J, Kwong KY, Warburton D, Ramanathan R, Jones CA, Minoo P. Bioactive transforming growth factor-β in the lungs of extremely low birthweight neonates predicts the need for home oxygen supplementation. Biol Neonate 77: 217-223, 2000.
15. Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, Verter J, Temprosa M, Wright LL, Ehrenkranz RA, Fanaroff AA, Stark A, Carlo W, Tyson JE, Donovan EF, Shankaran S, Stevenson DK. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 107: E1, 2001.
16. McGowan SE, Torday JS. The pulmonary lipofibroblast (lipid interstitial cell) and its contributions to alveolar development. Annu Rev Physiol 59: 43-62, 1997.
17. Mendelson CR. In: Endocrinology of the Lung. Totowa, NJ: Humana, 2000.
18. Miller NE. Techniques of early respiratory management of very low and extremely low birth weight infants. Neonatal Netw 29: 153-160, 2010.
19. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276: 357-368, 1967.
20. Pache JC, Christakos PG, Gannon DE, Mitchell JJ, Low RB, Leslie KO. Myofibroblasts in diffuse alveolar damage of the lung. Mod Pathol 11: 1064-1070, 1998.
21. Rehan V, Torday J. Hyperoxia augments pulmonary lipofibroblast-tomyofibroblast transdifferentiation. Cell Biochem Biophys 38: 239-250, 2003.
22. Rehan VK, Sakurai R, Corral J, Krebs M, Ibe B, Ihida-Stansbury K, Torday JS. Antenatally administered PPAR-γ agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury. Am J Physiol Lung Cell Mol Physiol 299: L672-L680, 2010.
23. Rehan VK, Wang Y, Patel S, Santos J, Torday JS. Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, prevents hyperoxiainduced neonatal rat lung injury in vivo. Pediatr Pulmonol 41: 558-569, 2006.
24. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA. Inhibition of adipogenesis by Wnt signaling. Science 289: 950-953, 2000.
25. 3 and its 3-epimer promote rat lung alveolar epithelial-mesenchymal interactions and inhibit lipofibroblast apoptosis. Am J Physiol Lung Cell Mol Physiol 297: L496-L505, 2009.
26. Schultz CJ, Torres E, Londos C, Torday JS. Role of adipocyte differentiation- related protein in surfactant phospholipid synthesis by type II cells. Am J Physiol Lung Cell Mol Physiol 283: L288-L296, 2002.
27. Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer 41: 1955-1968, 2005.
28. Shi W, Xu J, Warburton D. Development, repair and fibrosis: what is common and why it matters. Respirology 14: 656-665, 2009.
29. Smith MR, Gangireddy SR, Narala VR, Hogaboam CM, Standiford TJ, Christensen PJ, Kondapi AK, Reddy RC. Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycininduced lung injury. Am J Physiol Lung Cell Mol Physiol 298: L616-L625, 2010.
30. Sun J, Guo W, Ben Y, Jiang J, Tan C, Xu Z, Wang X, Bai C. Preventive effects of curcumin and dexamethasone on lung transplantation-associated lung injury in rats. Crit Care Med 36: 1205-1213, 2008.
31. Tontonoz P, Hu E, Spiegelman BM. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor γ. Curr Opin Genet Dev 5: 571-576, 1995.
32. Torday J, Hua J, Slavin R. Metabolism and fate of neutral lipids of fetal lung fibroblast origin. Biochim Biophys Acta 1254: 198-206, 1995.
33. Torday JS, Rehan VK. Developmental cell/molecular biologic approach to the etiology and treatment of bronchopulmonary dysplasia. Pediatr Res 62: 2-7, 2007.
34. Torday JS, Rehan VK. Lung evolution as a cipher for physiology. Physiol Genomics 38: 1-6, 2009.
35. Torday JS, Torday DP, Gutnick J, Qin J, Rehan V. Biologic role of fetal lung fibroblast triglycerides as antioxidants. Pediatr Res 49: 843-849, 2001.
36. Torday JS, Torres E, Rehan VK. The role of fibroblast transdifferentiation in lung epithelial cell proliferation, differentiation, and repair in vitro. Pediatr Pathol Mol Med 22: 189-207, 2003.
37. Toti P, Buonocore G, Tanganelli P, Catella AM, Palmeri ML, Vatti R, Seemayer TA. Bronchopulmonary dysplasia of the premature baby: an immunohistochemical study. Pediatr Pulmonol 24: 22-28, 1997.
38. Wang Y, Santos J, Sakurai R, Shin E, Cerny L, Torday JS, Rehan VK. Peroxisome proliferator-activated receptor γ agonists enhance lung maturation in a neonatal rat model. Pediatr Res 65: 150-155, 2009.
39. Zheng S, Chen A. Disruption of transforming growth factor-β signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-γ in rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 292: G113-G123, 2007.